FrostegrdJ
Source: (The Hindu) La Excellence IAS Academy , the best IAS coaching in Hyderabad , known for delivering quality content and conceptual clarity for UPSC 2026 preparation
The key safety consideration involves baseline health status: men with active prostate cancer, severe liver disease, or uncontrolled hypertension require individualized risk assessment before starting GLP-1 therapy alongside TRT
Long-term safety data is more limited at these doses
Semaglutide is currently FDA-approved for chronic weight management under the brand name Wegovy, with efficacy data from the STEP clinical trials supporting its use in adults with obesity or overweight with related comorbidities
This development highlights a few broader industry realities: Direct-to-consumer pharmaceutical marketing is entering a new era of scrutiny Telehealth platforms are now firmly within the regulatory spotlight Transparency around sourcing and manufacturing is becoming non-negotiable For life sciences companies, this moment reinforces something important: Innovation in delivery models whether telehealth, decentralized trials, or digital therapeutics must evolve in parallel with regulatory clarity and pharmacovigilance oversight